Clinical Trial Update: Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia [Phase 4]

View source ↗

Summary

This document discusses an ongoing Phase 4 clinical trial evaluating different idarubicin dosing regimens as induction therapy for newly diagnosed acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Idarubicin (idarubicin)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: UNKNOWN